Soligenix
SNGX
$0.32
Share price
-10.00%
Change (1 day)
-56.25%
Change (1 year)
Categories
Soligenix (SNGX) - Total assets
Total assets on the balance sheet as of March 2024 : $8.05 M
According to Soligenix's latest financial reports the company's total assets are $8.05 M. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Soligenix - Total assets on balance sheet (from 2001 to 2024)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $14.27 M | -46.86% |
| 2021-12-31 | $26.86 M | 35.08% |
| 2020-12-31 | $19.89 M | 155.82% |
| 2019-12-31 | $7.77 M | -25.89% |
| 2018-12-31 | $10.49 M | 9.86% |
| 2017-12-31 | $9.54 M | -6.99% |
| 2016-12-31 | $10.26 M | 38.99% |
| 2015-12-31 | $7.38 M | 6.22% |
| 2014-12-31 | $6.95 M | -15.86% |
| 2013-12-31 | $8.26 M | 75.67% |
| 2012-12-31 | $4.7 M | -42.79% |
| 2011-12-31 | $8.22 M | -11.27% |
| 2010-12-31 | $9.26 M | -1.23% |
| 2009-12-31 | $9.38 M | 179.07% |
| 2008-12-31 | $3.36 M | -11.13% |
| 2007-12-31 | $3.78 M | 168.94% |
| 2006-12-31 | $1.4 M | -58.28% |
| 2005-12-31 | $3.37 M | -33.45% |
| 2004-12-31 | $5.06 M | -18.94% |
| 2003-12-31 | $6.25 M | 7.09% |
| 2002-12-31 | $5.83 M | -47.13% |
| 2001-12-31 | $11.04 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $171.96 B | 2,133,902.12% | 🇺🇸 USA |
 Pfizer PFE | $221.09 B | 2,743,565.60% | 🇺🇸 USA |
 Sanofi SNY | $139.81 B | 1,734,938.56% | 🇫🇷 France |
 Onconova Therapeutics ONTX | $18.17 M | 125.50% | 🇺🇸 USA |
 Athersys ATHX | $7.42 M | -7.82% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $42.77 B | 530,689.07% | 🇮🇱 Israel |
 Cleveland BioLabs
CBLI | N/A | N/A | 🇺🇸 USA |
 Emergent BioSolutions
EBS | $1.80 B | 22,281.67% | 🇺🇸 USA |